Document is current
Any future updates will be listed below
-
Authors
Yoder, Alison K.
Lakomy, David S.
Dong, Yongquan
Raychaudhury, Suchismita
Royse, Kathryn
Hartman, Christine
Richardson, Peter
White, Donna L.
Kramer, Jennifer R.
Lin, Lilie L.
Chiao, Elizabeth http://orcid.org/0000-0001-5752-2916
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01CA206476)
U.S. Department of Veterans Affairs (CIN13-413, CX001430)
Dan L. Duncan Cancer Center, Baylor College of Medicine (P30CA022453)
- License Information
-
More Information
Article History
Received: 14 September 2020
Accepted: 15 June 2021
First Online: 5 July 2021
Declarations
:
: This study was approved by the IRB at Baylor College of Medicine. Protocol Number H-38727, Identifying novel pharmacologic risk factors for common non-AIDS defining cancers in individuals with well-controlled HIV infection.
: Not applicable.
: The authors declare that they have no competing interests.
